rdf:type |
|
lifeskim:mentions |
umls-concept:C0007559,
umls-concept:C0008633,
umls-concept:C0014834,
umls-concept:C0025252,
umls-concept:C0040975,
umls-concept:C0086597,
umls-concept:C0205314,
umls-concept:C0262880,
umls-concept:C0276640,
umls-concept:C0678118,
umls-concept:C0679622,
umls-concept:C0683598,
umls-concept:C1167331,
umls-concept:C1515926,
umls-concept:C1527240,
umls-concept:C1540034
|
pubmed:issue |
2
|
pubmed:dateCreated |
1990-8-27
|
pubmed:abstractText |
A clinical Escherichia coli isolate (MG32) resistant to ceftazidime but susceptible to other third-generation cephalosporins was previously examined and found to harbor TEM-1 and exhibit alterations in outer membrane proteins. Reexamination of this isolate revealed the additional presence of a novel TEM-1 derivative, now designated TEM-12. Evaluation of ceftazidime and cefotaxime minimum inhibitory concentrations for isogenic derivatives demonstrated a major role for TEM-12 in the decreased susceptibility observed. This was selectively enhanced for ceftazidime resistance by the altered porins of E. coli MG32. TEM-12 appeared identical to TEM-101, an in vitro TEM derivative, in both isoelectric point (pI 5.25) and substrate profile. Hybridization and cloning of the TEM-12 determinant revealed that, unlike other TEM derivatives, TEM-12 is chromosomally encoded, not plasmid-encoded.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1899
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
460-5
|
pubmed:dateRevised |
2008-8-22
|
pubmed:meshHeading |
pubmed-meshheading:2197339-Bacterial Outer Membrane Proteins,
pubmed-meshheading:2197339-Cefotaxime,
pubmed-meshheading:2197339-Ceftazidime,
pubmed-meshheading:2197339-Clavulanic Acids,
pubmed-meshheading:2197339-Deoxyribonuclease HindIII,
pubmed-meshheading:2197339-Drug Interactions,
pubmed-meshheading:2197339-Drug Resistance, Microbial,
pubmed-meshheading:2197339-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:2197339-Escherichia coli,
pubmed-meshheading:2197339-Humans,
pubmed-meshheading:2197339-Isoelectric Focusing,
pubmed-meshheading:2197339-Nucleic Acid Hybridization,
pubmed-meshheading:2197339-R Factors,
pubmed-meshheading:2197339-beta-Lactamases
|
pubmed:year |
1990
|
pubmed:articleTitle |
A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
|
pubmed:affiliation |
Department of Medical Microbiology, Creighton University School of Medicine, Omaha, Nebraska 68178.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|